Predicting the impact of biocorona formation kinetics on interspecies extrapolations of nanoparticle biodistribution modeling

Facing the Truth about Nanotechnology in Drug Delivery

(2013) Kinam Park   ACS Nano

Time Evolution of Nanoparticle–Protein Corona in Human Plasma: Relevance for Targeted Drug Delivery

(2013) Ana Lilia Barrán-Berdón et al.   LANGMUIR

Of mice, men and nanoparticle biocoronas: arein vitrotoin vivocorrelations and interspecies extrapolations realistic?

(2013) Jim E Riviere   Nanomedicine

Dynamic development of the protein corona on silica nanoparticles: composition and role in toxicity

(2013) Ninell P. Mortensen et al.   Nanoscale

Effect of polyethyleneglycol (PEG) chain length on the bio–nano-interactions between PEGylated lipid nanoparticles and biological fluids: from nanostructure to uptake in cancer cells

(2013) Daniela Pozzi et al.   Nanoscale

Transferrin-functionalized nanoparticles lose their targeting capabilities when a biomolecule corona adsorbs on the surface

(2013) Anna Salvati et al.   Nature Nanotechnology

Rapid formation of plasma protein corona critically affects nanoparticle pathophysiology

(2013) Stefan Tenzer et al.   Nature Nanotechnology

Dynamics of Nanoparticle-Protein Corona Complex Formation: Analytical Results from Population Balance Equations

(2013) Faryad Darabi Sahneh et al.   PLoS One

Correlating preclinical animal studies and human clinical trials of a multifunctional, polymeric nanoparticle

(2013) S. Eliasof et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Protein binding modulates the cellular uptake of silver nanoparticles into human cells: Implications for in vitro to in vivo extrapolations?

(2013) Nancy A. Monteiro-Riviere et al.   TOXICOLOGY LETTERS

Effects of the Presence or Absence of a Protein Corona on Silica Nanoparticle Uptake and Impact on Cells

(2012) Anna Lesniak et al.   ACS Nano

Delivery success rate of engineered nanoparticles in the presence of the protein corona: a systems-level screening

(2012) Daniele Dell'Orco et al.   Nanomedicine-Nanotechnology Biology and Medicine

Biomolecular coronas provide the biological identity of nanosized materials

(2012) Marco P. Monopoli et al.   Nature Nanotechnology

The Evolution of the Protein Corona around Nanoparticles: A Test Study

(2011) Martin Lundqvist et al.   ACS Nano

Factors Controlling Nanoparticle Pharmacokinetics: An Integrated Analysis and Perspective

(2011) S.M. Moghimi et al.   Annual Review of Pharmacology and Toxicology

Evolution of the Protein Corona of Lipid Gene Vectors as a Function of Plasma Concentration

(2011) Giulio Caracciolo et al.   LANGMUIR

In Vivo Delivery of Silica Nanorattle Encapsulated Docetaxel for Liver Cancer Therapy with Low Toxicity and High Efficacy

(2010) Linlin Li et al.   ACS Nano

Time Evolution of the Nanoparticle Protein Corona

(2010) Eudald Casals et al.   ACS Nano

An index for characterization of nanomaterials in biological systems

(2010) Xin-Rui Xia et al.   Nature Nanotechnology

Modeling the Time Evolution of the Nanoparticle-Protein Corona in a Body Fluid

(2010) Daniele Dell'Orco et al.   PLoS One

Comparison of Quantum Dot Biodistribution with a Blood-Flow-Limited Physiologically Based Pharmacokinetic Model

(2009) Hyun A. Lee et al.   NANO LETTERS

Pharmacokinetics of nanomaterials: an overview of carbon nanotubes, fullerenes and quantum dots

(2008) Jim E. Riviere   Wiley Interdisciplinary Reviews-Nanomedicine and Nanobiotechnology